Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
Synonyms: IBMPFD | Limb-girdle muscular dystrophy with Paget disease of bone | Pagetoid amyotrophic lateral sclerosis | Pagetoid neuroskeletal syndrome
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD) is a multisystem degenerative genetic disorder characterized by adult-onset proximal and distal muscle weakness (clinically resembling limb-girdle muscular dystrophy; see this term); early-onset Paget disease of bone (see this term) manifesting with bone pain deformity and enlargement of the long-bones; and premature frontotemporal dementia (see this term) manifesting first with dysnomia dyscalculia and comprehension deficits followed by progressive aphasia alexia and agraphia. As the disease progresses muscle weakness begins to affect the other limbs and respiratory muscles ultimately resulting in respiratory or cardiac failure.
Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.
Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version February 2024
Newly diagnosed with
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia?
Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.
Childhood Dementia Initiative
Childhood Dementia Initiative (CDI) is driving world first action in the consideration of the 70+ genetic conditions that cause childhood dementia under the one umbrella.
Genetic Support Network of Victoria
The Genetic Support Network of Victoria is an organisation that supports people living with genetic, undiagnosed and rare conditions and those who support them including community and families, patient support organisations, health professionals and industry. Our vision is our community flourishing and living their best lives.
KIF1A.ORG is a global community dedicated to improving the lives of those affected by KIF1A Associated Neurological Disorder (KAND) and accelerating research to find a cure.
To fund research for treatment and/or a cure for CASK Gene Disorder
For a list of clinical trials in this disease area, please click here.